PKP2 gene therapy reduces ventricular arrhythmias, reverses ventricular remodeling, improves heart function, and reduces mortality in a mouse model of arrhythmogenic right ventricular cardiomyopathy
Event:
EHRA 2024
Topic:
Cardiac Diseases
Session:
Basic science 1
/f/125658/4252x1496/43d16b540f/ehra-acronym-name-rgb.png)
